| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0be8d6cfb14d04522568dd6146ad713a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1993-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef036cbc096caa54ce6c4c368e8f4288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3635792fd2e958ed3f096baba94c348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7729ddbec1487191b6611bf7aaf520a0 |
| publicationDate |
1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0601508-B1 |
| titleOfInvention |
Liquid-suspension controlled-release pharmaceutical composition |
| abstract |
Disclosed is a liquid-suspension controlled-release enteric-coated pharmaceutical formulation for the administration of naproxen, comprising (a) microgranules of naproxen and an excipient; (b) four successive coatings of polymeric hydrophilic and hydrophobic materials, the first applied of said coatings imparting controlled-release properties to said naproxen according to a predetermined release profile; and (c) a liquid administration vehicle. This composition enables the oral administration of naproxen as a single daily dose and the adjustment of the dosage to a patient's requirements, thus aiding oral intake and minimizing the drug's typical side effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11523996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101209-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906145-B2 |
| priorityDate |
1992-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |